Drug Delivery System
About This Book
Drug Delivery System (MPH 102T) is written for students of the first semester of the Master of Pharmacy programme in Pharmaceutics, under the syllabus of the Pharmacy Council of India. It follows that syllabus unit by unit and keeps the weighting of its lecture hours, so the depth given to each topic matches the time the course allots to it.
Four ideas run through every chapter: release rate is designed rather than hoped for; the barrier decides the design; drug and polymer selection follows from both; and every claim made for a system must be proved by evaluation. Unit 1 of the syllabus combines sustained and controlled release, pharmaceutical polymers and dosage forms for personalised medicine; these are treated in two chapters so that release kinetics and polymer science are complete before personalised medicine is introduced. Chapters 3 to 8 correspond to Units 2 to 7.
Facts specific to marketed products, regulatory decisions and quantitative limits have been checked against prescribing information, regulatory documents and peer-reviewed reviews, which are cited at the end of each chapter. Where sources differ, the text says so. Product status and regulations change, and the student is advised to confirm the current position from the regulator before quoting it as law. Illustrative graphs are computed from stated models and are labelled as illustrative; they are not data from any product.
Table of Contents
- Sustained and Controlled Release Formulations and Polymers
- Dosage Forms for Personalized Medicine
- Rate-Controlled Drug Delivery Systems
- Gastro-Retentive and Buccal Drug Delivery Systems
- Ocular Drug Delivery Systems
- Transdermal Drug Delivery Systems
- Protein and Peptide Delivery
- Vaccine Delivery Systems
Keywords
How to Cite
Kumari, S., Rani, J., & Mahak. (2026). Drug Delivery System (1st ed.). WiseLeaf Scientific Ventures. ISBN: 978-81-181871-4-1
Paid Access — Preview the first 10 pages for free. Full book will be available for purchase through our partner platforms.